Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by MustangSalleyon Jun 27, 2021 8:37pm
110 Views
Post# 33458207

RE:RE:MDA

RE:RE:MDA

Mudlogger1 wrote: So why don't you post the info instead of giving us your weird as$ version?





i did 15% of float 39 million added to float , all management participate in it . Not only for new higher . $305 k spent on IR last 6 months . Burn rate will increase, 30 million will be gone within two years . New financing , more dilution , more options .

its 53 pages , why don't you go read it .  Before you criticized me for saying I was making all the fuss about compensation without any basis. The company posted it at last minute .

Give me your half glass full interpretation. I gave you my half glass piece . Read page 35 . Read about the so called past collaborations whereby they got excellent results but the major pharma company decided to walk away .  
 

No progress on immune coating .

Ms Sally 

<< Previous
Bullboard Posts
Next >>